Items tagged with Research and development
WHA 68: Experts discuss delinking drug R&D costs from pricing to make them affordable (post)
The problem of drug prices eating up national health budgets has been coming up at the annual World Health Assembly. Last week, a panel of experts discussed the merits of lowering those prices by delinking research and development costs from pricing.
Children, people with HIV, pregnant women and others underserved by TB drug development present ethical imperative, opportunities for global disease approaches, authors say (post)
Populations with needs that can and do affect the impacts of tuberculosis treatments are among the most vulnerable to the disease, make up significant proportions of the total of people sick with the disease worldwide, but are also the most neglected in TB drug development efforts. An article in a recently released Journal of Infectious Diseases supplement on tuberculosis drug development explores the challenges that developing products of appropriate doses and formulations for children, people with HIV, people with diabetes and pregnant women as well as the opportunities that meeting those challenges present.
Big pharma lacking in new antibiotic patents (post)
The antibiotics market is at risk of losing another decade to inadequate levels of research and innovation in favour of rare disease drugs, according to a new study.
UK’s Wellcome Trust to fund Sphaera Pharma’s MDR-tuberculosis drug development (post)
Hyderabad: Sphaera Pharma Pvt. Ltd, a Gurgaon-based drug discovery and development company, on Tuesday (July 21) said UK-based biomedical research charity Wellcome Trust had agreed to fund the development of its new drug to treat multiple drug-resistant tuberculosis (MDR-TB).
Why new antibiotics never come to market (post)
In the murky depths of Lake Michigan, around 15 feet below the surface, Brian Murphy is examining the various thickets of seaweed and vibrantly coloured sponges clinging to the sides of an old wooden cargo ship.
University students energise global campaign for medical R&D agreement (post)
The force of hundreds of students worldwide has gathered behind an international effort urging governments to promote research and development in a way that does not result in high-priced medicines. The initiative led by Universities Allied for Essential Medicines (UAEM) seeks to address the longstanding gap in affordable medicines and puts the focus on the World Health Organization, whose members are currently working on this issue.
EUPATI launches a new educational Toolbox on Medicines Research & Development for patient advocates (post)
-- More than 100 topics in 7 languages for patient advocates to discover, adapt and share!
-- Online information resource designed to enable more meaningful patient involvement!
-- Information and education to help engage patients and patient advocates!
WHO still on trail of new financing for R&D for poor populations’ medical needs (post)
World Health Organization members are expected to meet this spring to assess progress and discuss potential solutions to the lack of financing for research and development for diseases affecting primarily developing countries.
UN High-Level Panel: Ideas for change to global health and intellectual property system proliferate (post)
Public health advocates, academics, patients, governments and others this week presented further ideas to the United Nations Secretary-General’s High-Level Panel on Access to Medicines on ways to break the longstanding pattern of expensive medical products around the world as a way to pay for research and development.
As patients wait, WHO members chip away at decision on medical R&D funding (post)
09/05/2016 - A number of World Health Organization member states attended a meeting last week aimed finding ways to sustainably finance research and development for medical products, especially those for poor populations lacking means to pay high prices. According to the outcome document and a WHO official, they heard many viewpoints from experts and made progress but much was left for the World Health Assembly later this month.
Page 5 of 28 · Total posts: 0
←First 4 5 6 Last→